Employment Verification for Alnylam Pharmaceuticals.

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. It was founded in 2002 and specializes in RNA interference (RNAi) therapeutics. The company’s mission is to use RNAi technology to develop innovative therapies for patients with life-threatening diseases, such as genetic disorders, infectious diseases, and cancer. Alnylam’s flagship product is Onpattro (patisiran), the first RNAi therapeutic approved by the US Food and Drug Administration for the treatment of hereditary transthyretin-mediated amyloidosis. In addition to Onpattro, Alnylam has a robust pipeline of RNAi therapeutics in various stages of development, including drugs for the treatment of hemophilia, primary hyperoxaluria type 1, and hypercholesterolemia. Alnylam has established collaborations and partnerships with multiple pharmaceutical and biotechnology companies, such as Sanofi, Novartis, and Regeneron, to accelerate the development and commercialization of its RNAi therapeutics. The company has been recognized for its innovation and contribution to the field of RNAi therapeutics, receiving numerous awards and accolades, including being named one of the World’s Most Innovative Companies by Forbes magazine in 2018.

The information on this page is not an endorsement of Truv’s services by Alnylam Pharmaceuticals and is meant to be purely informational.

Verify Alnylam Pharmaceuticals Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.